| J2777 | Injection, faricimab‑svoa, 0.1 mg | 49,980 | $30 | $1.4M |
| J0178 | Injection, aflibercept, 1 mg | 460 | $690 | $318.3K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,320 | $180 | $235.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,260 | $100 | $123.3K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 950 | $90 | $80.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,640 | $30 | $47.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 370 | $90 | $32.9K |
| J3490 | Unclassified drugs | 90 | $200 | $17.7K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 80 | $210 | $16.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 120 | $120 | $13.5K |